Evidence map›Paper›PMID 36337308›Full record

ArticleWorld journal of clinical oncology2022

Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis.

Sa'ed H Zyoud, Amer Koni, Samah W Al-Jabi, Riad Amer, Muna Shakhshir, Rand Al Subu, Husam Salameh, Razan Odeh, Sultan Musleh, Faris Abushamma and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Sa'ed H ZyoudDepartment of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine. saedzyoud@yahoo.com.
Amer KoniDepartment of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine.
Samah W Al-JabiDepartment of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine.
Riad AmerHematology and Oncology Department, An-Najah National University Hospital, Nablus 44839, Palestine.
Muna ShakhshirDepartment of Nutrition, An-Najah National University Hospital, Nablus 44839, Palestine.
Rand Al SubuDepartment of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine.
Husam SalamehHematology and Oncology Department, An-Najah National University Hospital, Nablus 44839, Palestine.
Razan OdehHematology and Oncology Department, An-Najah National University Hospital, Nablus 44839, Palestine.
Sultan MuslehHematology and Oncology Department, An-Najah National University Hospital, Nablus 44839, Palestine.
Faris AbushammaDepartment of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine.
Adham Abu TahaDepartment of Pathology, An-Najah National University Hospital, Nablus 44839, Palestine.
An-Najah National University · PSNational University Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer is a severe public health issue that seriously jeopardizes global health. In individuals with coronavirus disease 2019 (COVID-19), cancer is considered an independent risk factor for severe illness and increased mortality.

aimTo identify research hotspots and prospects, we used bibliometrics to examine the global production of COVID-19 literature published in the field of oncology.

methodsData on publication output were identified based on the Scopus database between January 1, 2020, and June 21, 2022. This study used VOSviewer to analyze collaboration networks among countries and assess the terms most often used in the titles and abstracts of retrieved publications to determine research hotspots linked to cancer and COVID-19. The

resultsA total of 7015 publications were retrieved from the database. The United States published the greatest number of articles (2025; 28.87%), followed by Italy (964; 13.74%), the United Kingdom (839; 11.96%), and China (538; 7.67%). The

conclusionThis is the first bibliometric analysis to determine the present state and upcoming hot themes related to cancer and COVID-19 and vice versa using VOSviewer during the early stages of the pandemic. The emergence of hot themes related to cancer and COVID-19 may aid researchers in identifying new research areas in this field.

Indexed as

BibliometricCancerCoronavirus diseaseCOVID-19Reference Citation AnalysisScopusVOSviewer

Identifiers

PMID36337308
PMCPMC9630994
OpenAlexW4306784562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.